Carman Alenson's Net Worth
$683 Thousand
Who is Carman Alenson?
Carman Alenson does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include AGIOS PHARMACEUTICALS INC, and Prime Medicine, Inc..
SEC CIK
Carman Alenson's CIK is 0001688865
Past Insider Trading and Trends
2020 was Carman Alenson's most active year for acquiring shares with 7 total transactions. Carman Alenson's most active month to acquire stocks was the month of January. 2020 was Carman Alenson's most active year for disposing of shares, totalling 9 transactions. Carman Alenson's most active month to dispose stocks was the month of January. 2018 saw Carman Alenson paying a total of $142,960.86 for 17,384 shares, this is the most they've acquired in one year. In 2018 Carman Alenson cashed out on 5,620 shares for a total of $221,870.08, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AGIOS PHARMACEUTICALS INC (AGIO) Snapshot price: $43.28
Principal Accounting OfficerCarman Alenson used to own units in Common stock but no longer holds any shares there.acquired a total of 15,253 shares in AGIOS PHARMACEUTICALS INC at a cost of $234,494.13, Carman also disposed a total of 16,652 shares of AGIOS PHARMACEUTICALS INC equalling to $917,693.99.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$56.56 | -$17,947.70 |
0
|
Scheduled
|
Jun 21
| ||
Form 4
| -100.00% | -1.12K |
$55.89 | -$62,485.02 |
0
|
Scheduled
|
Apr 16
| ||
Form 4
| -46.99% | -991.00 |
$54.00 | -$53,514.00 | 1.12K |
Scheduled
|
Apr 15
| ||
Form 4
| +37.86% | 493 |
—
|
—
| 1.79K |
Feb 22
| |||
Form 4
| +607.61% | 1.12K |
—
|
—
| 1.3K |
Feb 14 - Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 4
| -57.60% | -250.00 |
$39.93 | -$9,982.50 | 184 |
Scheduled
|
Sep 2
| ||
Form 4
| -65.22% | -345.00 |
$47.30 | -$16,318.50 | 184 |
Scheduled
|
Mar 2
| ||
Form 4
| -71.95% | -472.00 |
$47.12 | -$22,240.64 | 184 |
Scheduled
|
Feb 26
| ||
Form 4
| +256.52% | 472 |
$48.66 | -$10,656.54 | 656 |
Feb 22 - Feb 24
| |||
Form 4
| -92.95% | -2.43K |
$53.37 | -$129,528.99 | 184 |
Scheduled
|
Feb 20
| ||
Form 4
| +1,319.02% | 2.43K |
$52.01 | -$60,487.63 | 2.61K |
Feb 14 - Feb 18
| |||
Form 4
| -94.13% | -2.95K |
$50.09 | -$147,765.50 | 184 |
Scheduled
|
Dec 26
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
| +446.09% | 2.28K |
$56.33 | -$57,231.28 | 2.8K |
Feb 21
| |||
Form 4
| +236.84% | 360 |
$64.54 | -$27,752.74 | 512 |
Sep 28 - Feb 19
| |||
Form 4
|
—
|
0
|
$67.65 | -$9,581.52 | 152 |
Scheduled
|
Sep 5
| ||
Form 4
|
—
|
0
|
$68.61 | -$8,880.80 |
0
|
Scheduled
|
Jul 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
$63.65 | -$48,826.50 |
0
|
Scheduled
|
Jan 12
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Prime Medicine, Inc. (PRME) Snapshot price: $3.4303
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||